Comparison of American and European Guidelines for the Management of Patients With Valvular Heart Disease

Basit Öğe Kaydı
dc.authoridINANC, IBRAHIM HALIL/0000-0003-4046-6748
dc.authoridMatar, Fadi/0000-0002-5064-0052
dc.contributor.authorInanc, Ibrahim Halil
dc.contributor.authorCilingiroglu, Mehmet
dc.contributor.authorIliescu, Cezar
dc.contributor.authorNInios, Vlasis
dc.contributor.authorMatar, Fadi
dc.contributor.authorAtes, Ismail
dc.contributor.authorToutouzas, Konstantinos
dc.date.accessioned2025-01-21T16:36:45Z
dc.date.available2025-01-21T16:36:45Z
dc.date.issued2023
dc.departmentKırıkkale Üniversitesi
dc.description.abstractThis review compares the recommendations of the recent 2020 American College of Cardiology (ACC)/American Heart Association (AHA) and 2021 European Society of Cardiology (ESC)/European Association for CardioThoracic Surgery (EACTS) guidelines on the management of patients with valvular heart disease (VHD). ACC/ AHA and ESC/EACTS guidelines are both the updated versions of previous 2017 documents. Both guidelines fundamentally agree on the extended indications of percutaneous valve interventions, the optimal use of imaging modalities other than 2D echocardiography, the importance of a multidisciplinary Heart Team as well as active patient participation in clinical decision making, more widespread use of NOACs and earlier intervention with lower left ventricular dilatation thresholds to decrease long-term mortality. The differences between the guidelines are mainly related to the classification of the severity of valve pathologies and frequency of follow-up, level of recommendations of valve intervention indications in special patient groups such as frail patients and the left ventricular diameter and ejection fraction thresholds for intervention. (c) 2022 Elsevier Inc. All rights reserved.
dc.identifier.doi10.1016/j.carrev.2022.10.005
dc.identifier.endpage85
dc.identifier.issn1553-8389
dc.identifier.issn1878-0938
dc.identifier.pmid36270966
dc.identifier.startpage76
dc.identifier.urihttps://doi.org/10.1016/j.carrev.2022.10.005
dc.identifier.urihttps://hdl.handle.net/20.500.12587/24379
dc.identifier.volume47
dc.identifier.wosWOS:000925571400001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Inc
dc.relation.ispartofCardiovascular Revascularization Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_20241229
dc.subjectValvular heart disease; ESC; ACC; AHA
dc.titleComparison of American and European Guidelines for the Management of Patients With Valvular Heart Disease
dc.typeReview Article

Dosyalar

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu